Scientists from around the world attended a symposium at Columbia to celebrate the 80th birthday of Tom Maniatis and his contributions to the field of molecular biology.
The center will catalyze the scientific innovation and clinical implementation of precision medicine to advance the prevention, diagnosis, and treatment of mental illness.
From a chatbot that suggests the healthiest breakfast to an algorithm that finds dangerous drug interactions, Columbia researchers are using analytics to help transform many aspects of clinical care.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Data collected by cars on driver performance—combined with machine learning—could detect elderly drivers who will soon develop mild cognitive impairment or dementia.
A new device that calms overactive kidney nerves with ultrasound consistently lowered blood pressure in patients with uncontrolled hypertension, Columbia researchers found.
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
New research reveals differences in the gut microbiomes of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to those of healthy controls.